Retrospective analysis of clinical and molecular characteristics as prognostic factors in adult T-cell lymphoblastic lymphoma
- Li Ma 1, Jing Wang 2, Jin Zhao 1, Meijing Zheng 1, Xiaolian Wen 1, Liping Su 1
- 1Department of Hematology, Cancer Hospital Affiliated to Shanxi Medical University/Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences Taiyuan 030013, Shanxi, China.
- 2Department of Pathology, Cancer Hospital Affiliated to Shanxi Medical University/Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences Taiyuan 030013, Shanxi, China.
- 0Department of Hematology, Cancer Hospital Affiliated to Shanxi Medical University/Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences Taiyuan 030013, Shanxi, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Adult T-cell lymphoblastic lymphoma (T-LBL) often presents with advanced disease and frequent mutations. Female sex, lack of complete response, and high LDH levels predict poor survival, guiding targeted therapy development.
Area Of Science
- Hematology
- Oncology
- Molecular Biology
Background
- Adult T-cell lymphoblastic lymphoma (T-LBL) is an aggressive hematologic malignancy.
- Understanding its clinical and molecular landscape is crucial for improving patient outcomes.
Purpose Of The Study
- To analyze clinical characteristics and molecular biomarkers of T-LBL.
- To identify prognostic factors and evaluate chemotherapy efficacy.
- To provide a basis for optimizing T-LBL treatment strategies.
Main Methods
- Retrospective analysis of 89 adult T-LBL patients.
- Collection of clinical data, treatment details, and mutational profiles.
- Assessment of prognostic factors and comparison of two chemotherapy regimens.
Main Results
- Most patients presented with advanced disease (stages III-IV), mediastinal invasion (70.80%), and B symptoms (66.30%).
- NOTCH1 was the most frequent mutation, followed by PHF-6, JAK-1, JAK-3, IL-7R, and TP53.
- Complete response rate was 51.69%; 3-year OS and PFS were 74.9% and 58.80%, respectively.
- Independent predictors of poor overall survival included female sex, lack of complete response, and elevated LDH levels.
Conclusions
- T-LBL exhibits frequent gene mutations in signaling pathways.
- Mediastinal and extranodal involvement are prevalent and associated with poor prognosis in Chinese patients.
- Combined clinical and molecular assessment improves prognostic stratification and aids targeted therapy development for high-risk T-LBL patients.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
03:18
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
01:21
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

